1 |
Finsterer J. Primary periodic paralyses. Acta Neurol Scand 2008;117:145-58.
DOI
ScienceOn
|
2 |
Sternberg D, Tabti N, Hainque B, Fontaine B. Hypokalemic periodic paralysis [Internet]. Seattle: University of Washington; 2002 [updated 2009 April 28; cited 2011 Jan 4]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1338/.
|
3 |
Jurkat-Rott K, Lehmann-Horn F, Elbaz A, Heine R, Gregg RG, Hogan K, et al. A calcium channel mutation causing hypokalemic periodic paralysis. Hum Mol Genet 1994;3:1415-9.
DOI
ScienceOn
|
4 |
Kuzmenkin A, Hang C, Kuzmenkina E, Jurkat-Rott K. Gating of the HypoPP-1 mutations: I. Mutant-specific effects and cooperativity. Pflugers Arch 2007;454:495-505.
DOI
ScienceOn
|
5 |
Rudel R, Lehmann-Horn F, Ricker K, Küther G. Hypokalemic periodic paralysis: in vitro investigation of muscle fiber membrane parameters. Muscle Nerve 1984;7:110-20.
DOI
ScienceOn
|
6 |
Kuzmenkin A, Muncan V, Jurkat-Rott K, Hang C, Lerche H, Lehmann- Horn F, et al. Enhanced inactivation and pH sensitivity of Na(+) channel mutations causing hypokalaemic periodic paralysis type II. Brain 2002; 125(Pt 4):835-43.
DOI
|
7 |
Venance SL, Jurkat-Rott K, Lehmann-Horn F, Tawil R. SCN4A -associated hypokalemic periodic paralysis merits a trial of acetazolamide. Neurology 2004;63:1977.
DOI
ScienceOn
|
8 |
Kim MK, Lee SH, Park MS, Kim BC, Cho KH, Lee MC, et al. Mutation screening in Korean hypokalemic periodic paralysis patients: a novel SCN4A Arg672Cys mutation. Neuromuscul Disord 2004;14:727-31.
DOI
ScienceOn
|
9 |
Bendahhou S, Cummins TR, Griggs RC, Fu YH, Ptácek LJ. Sodium channel inactivation defects are associated with acetazolamide-exacerbated hypokalemic periodic paralysis. Ann Neurol 2001;50:417-20.
DOI
ScienceOn
|
10 |
Sternberg D, Maisonobe T, Jurkat-Rott K, Nicole S, Launay E, Chauveau D, et al. Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A . Brain 2001;124 (Pt 6):1091-9.
|
11 |
Miller TM, Dias da Silva MR, Miller HA, Kwiecinski H, Mendell JR, Tawil R, et al. Correlating phenotype and genotype in the periodic paralyses. Neurology 2004;63:1647-55.
DOI
ScienceOn
|
12 |
Kim JB, Kim MH, Lee SJ, Kim DJ, Lee BC. The genotype and clinical phenotype of Korean patients with familial hypokalemic periodic paralysis. J Korean Med Sci 2007;22:946-51.
DOI
ScienceOn
|
13 |
Ruff RL. Insulin acts in hypokalemic periodic paralysis by reducing inward rectifier K+ current. Neurology 1999;53:1556-63.
DOI
|
14 |
Jurkat-Rott K, Mitrovic N, Hang C, Kouzmekine A, Iaizzo P, Herzog J, et al. Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. Proc Natl Acad Sci U S A 2000;97:9549-54.
DOI
ScienceOn
|
15 |
Cannon SC. An expanding view for the molecular basis of familial periodic paralysis. Neuromuscul Disord 2002;12:533-43.
DOI
ScienceOn
|
16 |
Morrill JA, Cannon SC. Effects of mutations causing hypokalaemic periodic paralysis on the skeletal muscle L-type Ca2+ channel expressed in Xenopus laevis oocytes. J Physiol 1999;520 Pt 2:321-36.
|
17 |
Tricarico D, Servidei S, Tonali P, Jurkat-Rott K, Camerino DC. Impairment of skeletal muscle adenosine triphosphate-sensitive K+ channels in patients with hypokalemic periodic paralysis. J Clin Invest 1999;103:675-82.
DOI
ScienceOn
|